Citigroup
AIDX icon

Citigroup’s 20/20 Biolabs Inc AIDX Stock Holding History

Citigroup’s Portfolio AIDX Stock Details AIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Buy
+1
New +$1 ﹤0.01% 6405

Other funds holding AIDX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
McDonald Partners
McDonald Partners Cleveland, Ohio $423M AUM 27.93% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Citigroup's AIDX Position: Q3 2026 in Review

Citigroup opened a new position in 20/20 Biolabs Inc (AIDX) in Q3 2026: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #6405 among its holdings.

5 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.

  • Citigroup held 1 share of 20/20 Biolabs Inc worth $0 as of Q3 2026.
  • 20/20 Biolabs Inc was a new Citigroup position in Q3 2026.
  • 20/20 Biolabs Inc made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #6405 holding.
  • 5 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.